Bugworks Research, an India-based clinical-stage biopharmaceutical company, announced on Wednesday that it has named Dr Renu Swarup as a honorary member of the Global Advisory Board.
Dr Swarup has served as the secretary, Department of Biotechnology, Government of India and brings in over three decades of experience in the biotech sector. She has served as the founding managing director, Biotechnology Industry Research Assistance Council (BIRAC) and as a fellow of the National Academy of Sciences, India (NASI) and actively supported women scientists as a member of the prime minister's Scientific Advisory Committee's task force on women in science. Dr Swarup is a part of The Organization for Women in Science for the Developing World.
Dr Anand Anandkumar - CEO, Bugworks Research said, 'Bugworks is pleased to welcome Dr Renu Swarup as a member of its Global Advisory Board. Dr Swarup, an accomplished geneticist, was formerly the secretary, Department of Biotechnology, Ministry of Science & Technology, India. She was one of the key architects to formulate India's Biotechnology Vision and Strategy including the COVID-19 vaccine roll-out initiatives. Under her inspirational leadership, Biotechnology Industry Research Assistance Council (BIRAC) has ushered in a new wave of biotech SMEs and start-ups, of which Bugworks was an early benefactor. We look forward to working closely with Dr Swarup to help us reach our goal of enabling equitable global access to Bugworks' innovative products.'
Circio Holding and Entos Pharmaceuticals collaborate on circular RNA delivery
AKAGERA Medicines completes first cohort in phase 1 SAD/MAD study of AKG-100
Alzinova AB reports positive final Phase 1b results for ALZ-101 in Alzheimer's
Primrose Bio launches Prima RNApols ExTend RNA polymerase for long-template mRNA manufacturing
Merck's CAPVAXIVE approved by EC for pneumococcal disease prevention
Sanofi secures FDA fast track designation for chlamydia vaccine candidate
Anixa Biosciences secures US patent allowance for ovarian cancer vaccine
Valneva to supply IXCHIQ vaccine for chikungunya outbreak in La Réunion
Everest Medicines' EVM14 IND application receives US FDA approval
Clover Biopharmaceuticals' SCB-1019 IND application receives US FDA approval
Centivax partners with Emery Pharma on universal flu vaccine
Avance Biosciences registers with CLIA program
GSK receives approval from US FDA for Penmenvy 5-in-1 meningitis vaccine
hVIVO secures GBP2m contract for final stage of hMPV characterisation study
EU approves CSL and Arcturus Therapeutics' self-amplifying mRNA COVID-19 vaccine